TACE is Required for the Activation of the EGFR by TGF-alpha in Tumors

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 2003 Feb 28

PMID 12606576

Citations 111

Authors

Maria Borrell-Pages

Federico Rojo

Joan Albanell

Josep Baselga

Joaquin Arribas

Affiliations

Soon will be listed here.

Abstract

The factors and mechanisms that transduce the intracellular signals sent upon activation of the receptor for the epidermal growth factor (EGFR) and related receptors are reasonably well understood and, in fact, are the targets of anti-tumor drugs. In contrast, less is known about the mechanisms implicated in sending the signals that activate these receptors. Here we show that when its proteolytic shedding is prevented, the transmembrane form of the transforming growth factor-alpha (proTGF-alpha) interacts with, but does not activate, the EGFR. Thus, shedding seems to control not only the availability of the soluble form of the growth factor (TGF-alpha) but also the activity of the transmembrane form. The activity of the protease responsible for the shedding of proTGF-alpha, tumor necrosis factor-alpha converting enzyme (TACE), is required for the activation of the EGFR in vivo and for the development of tumors in nude mice, indicating a crucial role of TACE in tumorigenesis. In agreement with this view, TACE is dramatically overexpressed in the majority of mammary tumors analyzed. Collectively, this evidence points to TACE as a promising target of anti-tumor therapy.

Citing Articles

Age-dependent changes on fractalkine forms and their contribution to neurodegenerative diseases.

Eugenin J, Eugenin-von Bernhardi L, von Bernhardi R Front Mol Neurosci. 2023; 16:1249320.

PMID: 37818457 PMC: 10561274. DOI: 10.3389/fnmol.2023.1249320.

Analysis of the function of ADAM17 in iRhom2 curly-bare and tylosis with esophageal cancer mutant mice.

Rabinowitsch A, Maretzky T, Weskamp G, Haxaire C, Tueshaus J, Lichtenthaler S J Cell Sci. 2023; 136(13).

PMID: 37282854 PMC: 10357010. DOI: 10.1242/jcs.260910.

The ADAM17 sheddase complex regulator iTAP/Frmd8 modulates inflammation and tumor growth.

Badenes M, Burbridge E, Oikonomidi I, Amin A, de Carvalho E, Kosack L Life Sci Alliance. 2023; 6(4).

PMID: 36720499 PMC: 9889915. DOI: 10.26508/lsa.202201644.

Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab.

Fabbi M, Costa D, Russo D, Arenare L, Gaggero G, Signoriello S Diagnostics (Basel). 2022; 12(9).

PMID: 36140519 PMC: 9498026. DOI: 10.3390/diagnostics12092118.

Characterization of the roles of amphiregulin and transforming growth factor β1 in microvasculature-like formation in human granulosa-lutein cells.

Li H, Chang H, Li S, Klausen C, Shi Z, Leung P Front Cell Dev Biol. 2022; 10:968166.

PMID: 36092732 PMC: 9448859. DOI: 10.3389/fcell.2022.968166.

References

Dong J, Opresko L, Dempsey P, Lauffenburger D, Coffey R, Wiley H . Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor. Proc Natl Acad Sci U S A. 1999; 96(11):6235-40. PMC: 26865. DOI: 10.1073/pnas.96.11.6235. View

Arribas J, Massague J . Transforming growth factor-alpha and beta-amyloid precursor protein share a secretory mechanism. J Cell Biol. 1995; 128(3):433-41. PMC: 2120346. DOI: 10.1083/jcb.128.3.433. View

Hattori M, Osterfield M, Flanagan J . Regulated cleavage of a contact-mediated axon repellent. Science. 2000; 289(5483):1360-5. DOI: 10.1126/science.289.5483.1360. View

Baselga J . Targeting the epidermal growth factor receptor: a clinical reality. J Clin Oncol. 2001; 19(18 Suppl):41S-44S. View

Coussens L, Tinkle C, Hanahan D, Werb Z . MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell. 2000; 103(3):481-90. PMC: 2843102. DOI: 10.1016/s0092-8674(00)00139-2. View

Dempsey P, Coffey R . Basolateral targeting and efficient consumption of transforming growth factor-alpha when expressed in Madin-Darby canine kidney cells. J Biol Chem. 1994; 269(24):16878-89. View

Lee J, Urban S, Garvey C, Freeman M . Regulated intracellular ligand transport and proteolysis control EGF signal activation in Drosophila. Cell. 2001; 107(2):161-71. DOI: 10.1016/s0092-8674(01)00526-8. View

Bergers G, Coussens L . Extrinsic regulators of epithelial tumor progression: metalloproteinases. Curr Opin Genet Dev. 2000; 10(1):120-7. DOI: 10.1016/s0959-437x(99)00043-x. View

Kuo A, Zhong C, Lane W, Derynck R . Transmembrane transforming growth factor-alpha tethers to the PDZ domain-containing, Golgi membrane-associated protein p59/GRASP55. EMBO J. 2000; 19(23):6427-39. PMC: 305863. DOI: 10.1093/emboj/19.23.6427. View

10.

Izumi Y, Hirata M, Hasuwa H, Iwamoto R, Umata T, Miyado K . A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J. 1998; 17(24):7260-72. PMC: 1171072. DOI: 10.1093/emboj/17.24.7260. View

11.

Jhappan C, Stahle C, Harkins R, Fausto N, Smith G, Merlino G . TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell. 1990; 61(6):1137-46. DOI: 10.1016/0092-8674(90)90076-q. View

12.

Baselga J, Arribas J . Metalloprotease-dependent protransforming growth factor-alpha ectodomain shedding in the absence of tumor necrosis factor-alpha-converting enzyme. J Biol Chem. 2001; 276(51):48510-7. DOI: 10.1074/jbc.M103488200. View

13.

Weskamp G, Cai H, Brodie T, Higashyama S, Manova K, Ludwig T . Mice lacking the metalloprotease-disintegrin MDC9 (ADAM9) have no evident major abnormalities during development or adult life. Mol Cell Biol. 2002; 22(5):1537-44. PMC: 134708. DOI: 10.1128/MCB.22.5.1537-1544.2002. View

14.

Urban S, Lee J, Freeman M . Drosophila rhomboid-1 defines a family of putative intramembrane serine proteases. Cell. 2001; 107(2):173-82. DOI: 10.1016/s0092-8674(01)00525-6. View

15.

Black R, Rauch C, Kozlosky C, Peschon J, Slack J, Wolfson M . A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature. 1997; 385(6618):729-33. DOI: 10.1038/385729a0. View

16.

Arribas J, Coodly L, Vollmer P, Kishimoto T, Rose-John S, Massague J . Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J Biol Chem. 1996; 271(19):11376-82. DOI: 10.1074/jbc.271.19.11376. View

17.

Kheradmand F, Werb Z . Shedding light on sheddases: role in growth and development. Bioessays. 2002; 24(1):8-12. DOI: 10.1002/bies.10037. View

18.

Albanell J, Codony-Servat J, Rojo F, Del Campo J, Sauleda S, Anido J . Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments. Cancer Res. 2001; 61(17):6500-10. View

19.

Moss M, Jin S, Milla M, Bickett D, Burkhart W, Carter H . Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature. 1997; 385(6618):733-6. DOI: 10.1038/385733a0. View

20.

Fernandez-Larrea J, Urena J, Baselga J, Arribas J . A role for a PDZ protein in the early secretory pathway for the targeting of proTGF-alpha to the cell surface. Mol Cell. 1999; 3(4):423-33. DOI: 10.1016/s1097-2765(00)80470-0. View